Nucleic Acid Targeted Drug Design (Propst, C. L.; Perun, Thomas J.)

1993 ◽  
Vol 70 (7) ◽  
pp. A199
Keyword(s):  
Nucleic Acid ◽  
Drug Design ◽  
Targeted Drug

Nucleic acid targeted drug design

1993 ◽  
Vol 14 (10) ◽  
pp. 385-386
Author(s):  
James M. Veal
Keyword(s):  
Nucleic Acid ◽  
Drug Design ◽  
Targeted Drug

Molecular Modeling in Nucleic Acid-Targeted Drug Design

2011 ◽  
pp. 258-271
Author(s):  
Lidan Sun ◽  
Hongwei Jin ◽  
Liangren Zhang ◽  
Lihe Zhang
Keyword(s):  
Molecular Modeling ◽  
Nucleic Acid ◽  
Drug Design ◽  
Targeted Drug

Nucleic acid targeted drug design

1994 ◽  
Vol 12 (1) ◽  
pp. 33
Author(s):  
Michael J. Waring
Keyword(s):  
Nucleic Acid ◽  
Drug Design ◽  
Targeted Drug

The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy

2019 ◽  
Vol 18 (28) ◽  
pp. 2380-2394 ◽  
Author(s):  
Na Liu ◽  
Rongtong Zhao ◽  
Yue Ma ◽  
Dongyuan Wang ◽  
Chen Yan ◽  
...  
Keyword(s):  
Drug Design ◽  
Rapid Development ◽  
Epigenetic Changes ◽  
Disease Treatment ◽  
Nucleosome Remodeling ◽  
Epigenetic Modifiers ◽  
The Us ◽  
Targeted Drug ◽  
Heritable Change ◽  
Lymphoma Therapy

Epigenetics process is the heritable change in gene function that does not involve changes in the DNA sequence. Until now, several types of epigenetic mechanisms have been characterized, including DNA methylation, histone modification (acetylation, methylation, etc.), nucleosome remodeling, and noncoding RNAs. With the biological investigations of these modifiers, some of them are identified as promoters in the process of various diseases, such as cancer, cardiovascular disease and virus infection. Epigenetic changes may serve as potential “first hits” for tumorigenesis. Hence, targeting epigenetic modifiers is being considered as a promising way for disease treatment. To date, six agents in two epigenetic target classes (DNMT and HDAC) have been approved by the US Food and Drug Administration (FDA). Most of these drugs are applied in leukemia, lymphoma therapy, or are combined with other drugs for the treatment of solid tumor. Due to the rapid development of epigenetics and epigenetics targeted drugs, it is becoming an emerging area in targeted drug design.

Sign in / Sign up

Export Citation Format

Share Document